Mineralys Therapeutics, Inc. (MLYS)

Mineralys Therapeutics, Inc. (MLYS) is a healthcare company (biotechnology) based in the United States. The share price is $14.63, up 0.69% on the day, which values the company at $1.3B. Price as of 17 Nov 2026, 17:28 UTC, from Yahoo Finance.

Key facts

Share price
$14.63+0.69% today
Market value
$1.3B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Mineralys Therapeutics, Inc. in more detail

MLYS trades at -5.6× next year's expected earnings.

1 of the superinvestors tracked here hold MLYS, including Peter Kolchinsky (1.8% of the portfolio).

Superinvestors holding MLYS

1 of the investors tracked here report a position in their latest 13F filing.

Mineralys Therapeutics, Inc. (MLYS): questions and answers

What is Mineralys Therapeutics, Inc.'s market cap?

Mineralys Therapeutics, Inc. is valued at $1.3B at a share price of $14.63.

Does MLYS pay a dividend?

Mineralys Therapeutics, Inc. does not currently pay a regular dividend.

Which famous investors own MLYS?

In their latest quarterly filings, Peter Kolchinsky (1.8% of the portfolio) hold MLYS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Mineralys Therapeutics, Inc. (MLYS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/MLYS

Underlying data: Yahoo Finance; company filings with the SEC.